simendan has been researched along with Coronary Heart Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leprán, I; Papp, JG | 1 |
| Blome, M; Boldt, J; Isgro, F; Lang, J; Lehmann, A | 1 |
| Kleber, FX; Lehtonen, LA; Sonntag, S; Sundberg, S | 1 |
| Akgul, A; Cobanoglu, A; Katircioglu, SF; Mavioglu, L; Pac, M | 1 |
| Jirmar, R; Kolesar, M; Nejedly, M; Vanek, T | 1 |
| Akkila, J; Heikkilä, L; Kuitunen, A; Lehtonen, L; Lilleberg, J; Mattila, S; Nieminen, MS; Salmenperä, M; Verkkala, K | 1 |
| du Toit, E; Hofmann, D; McCarthy, J; Pineda, C | 1 |
2 trial(s) available for simendan and Coronary Heart Disease
| Article | Year |
|---|---|
The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiac Volume; Cardiotonic Agents; Coronary Circulation; Coronary Disease; Diastole; Double-Blind Method; Female; Humans; Hydrazones; Male; Middle Aged; Myocardial Ischemia; Myocardial Stunning; Pyridazines; Simendan; Systole; Treatment Outcome; Vasodilation; Vasodilator Agents; Ventricular Function, Left; Ventricular Pressure | 2004 |
Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting.
Topics: Adult; Aged; Analysis of Variance; Cardiac Output; Cardiotonic Agents; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Myocardium; Oxygen Consumption; Postoperative Care; Postoperative Period; Pyridazines; Simendan; Stroke Volume; Treatment Outcome; Vascular Resistance | 1998 |
5 other study(ies) available for simendan and Coronary Heart Disease
| Article | Year |
|---|---|
Effect of long-term oral pretreatment with levosimendan on cardiac arrhythmias during coronary artery occlusion in conscious rats.
Topics: Administration, Oral; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Consciousness; Coronary Disease; Dose-Response Relationship, Drug; Electrocardiography; Heart; Heart Rate; Hydrazones; Male; Myocardial Ischemia; Pyridazines; Rats; Rats, Sprague-Dawley; Simendan; Time Factors | 2003 |
[Is levosimendan an inoprotective drug in patients with acute coronary syndrome undergoing surgical revascularization?].
Topics: Adult; Aged; ATP-Binding Cassette Transporters; Cardiotonic Agents; Coronary Disease; Female; Hemodynamics; Humans; Hydrazones; KATP Channels; Male; Middle Aged; Mitral Valve Insufficiency; Myocardial Infarction; Myocardial Revascularization; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pyridazines; Simendan | 2003 |
Levosimendan for weaning from cardiopulmonary bypass after coronary artery bypass grafting.
Topics: Aged; Blood Pressure; Cardiopulmonary Bypass; Cardiotonic Agents; Coronary Artery Bypass; Coronary Disease; Female; Follow-Up Studies; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Postoperative Care; Pyridazines; Simendan; Stroke Volume; Treatment Outcome; Ventilator Weaning | 2006 |
Rescue peri-operative management of the patient with giant electrical storm and severe left ventricular dysfunction: support by levosimendan and intraaortic balloon counterpulsation.
Topics: Aortic Valve Stenosis; Cardiac Pacing, Artificial; Cardiopulmonary Bypass; Cardiotonic Agents; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Echocardiography; Heart Valve Prosthesis Implantation; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Male; Middle Aged; Perioperative Care; Pyridazines; Simendan; Tachycardia, Ventricular; Treatment Outcome; Ventricular Dysfunction, Left | 2008 |
Effect of levosimendan on myocardial contractility, coronary and peripheral blood flow, and arrhythmias during coronary artery ligation and reperfusion in the in vivo pig model.
Topics: Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Coronary Circulation; Coronary Disease; Hydrazones; Male; Models, Animal; Myocardial Contraction; Pyridazines; Regional Blood Flow; Simendan; Swine; Vascular Resistance | 2001 |